About David Stout
Form D filings for BlueWillow Biologics from 2009 to 2024 list David Stout as director.
David Stout first appears on SEC filings in 2009.
Experience
This experience comes from SEC filings. The years are when the filings name David Stout in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Stout works with at each company, as listed on that company's latest Form D.
BlueWillow Biologics, Inc. · Form D, Feb 12, 2024
PW
Phil Wilmington
Director
RO
Roger D'Orazio
Director
GA
George Arida
Executive officer
HB
Hugo Braun
Director
CC
Chad Costley
President & Chief Executive Officer, director